Showing results (131-140 of 226) with videos related to
Sort By:
Pageof 23
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Trophoblastic disease review for diagnosis and management: a joint report from the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroupGiorgia Mangili, Domenica Lorusso, Jubilee Brown, et al.Bulletin Du Cancer|May 21, 2022
[hPG80 and cancer: A new blood biomarker in development for patient monitoring]Benoit You, Eric Assenat, Léa Payen, et al.JNCI Cancer Spectrum|June 30, 2020
Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7)Olivier Colomban, Michel Tod, Julien Peron, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Clinical impact of CA-125 ELIMination rate constant K (KELIM) on surgical strategy in advanced serous ovarian cancer patientsBarnabe Bouvarel, Oliver Colomban, Jean-Sebastien Frenel, et al.Annals of Surgical Oncology|October 29, 2021
Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort StudyVahan Kepenekian, Julien Péron, Benoit You, et al.Critical Reviews in Oncology/Hematology|February 2, 2015
Concomitant drugs with low risks of drug-drug interactions for use in oncology clinical trialsFlorence Ranchon, Thierry Vial, Catherine Rioufol, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 19, 2024
Clinical impact of CA-125 ELIMination rate constant K (KELIM) on surgical strategy in advanced serous ovarian cancer patientsBarnabe Bouvarel, Oliver Colomban, Jean-Sebastien Frenel, et al.Cancers|April 3, 2021
Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC StudyMartinez Alejandra, Witold Gertych, Christophe Pomel, et al.Journal of Clinical Medicine|May 8, 2020
Ovarian Cancer in the Elderly: Time to Move towards a More Logical Approach to Improve Prognosis-A Study from the FRANCOGYN GroupLudivine Dion, Camille Mimoun, Krystel Nyangoh Timoh, et al.Cancers|February 11, 2023
A Suggested Modification to FIGO Stage IV Epithelial Ovarian CancerMarie Métairie, Louise Benoit, Meriem Koual, et al.Pageof 23